Products A-Z
Below you can find a full list of our products.
Our medicines and vaccines are approved in individual countries for specific uses and the information we provide is governed by local regulation. Patients should always ask a healthcare professional for advice.
Healthcare professionals seeking information on our medicines, vaccines and educational resources, please visit your local GSKPro website.
Visit our worldwide directory to find where we operate and local website details.
Filter updated: : All product areas, All therapy areas
| Trademark | Generic | Product area | Therapy area |
|---|---|---|---|
| Anoro Ellipta | umeclidinium bromide/vilanterol trifenatate | General medicines | Respiratory, Immunology and Inflammation |
| Apretude | cabotegravir | Specialty medicines | HIV |
| Arexvy | respiratory syncytial virus vaccine | Vaccines | Infectious diseases |
| Augmentin | amoxicillin trihydrate/potassium clavulanate | General medicines | Infectious diseases |
| Benlysta, Benlysta (SC and IV) | belimumab | Specialty medicines | Respiratory, Immunology and Inflammation |
| Bexsero | meningococcal group-B vaccine | Vaccines | Infectious diseases |
| Blenrep | belantamab mafodotin | Specialty medicines | Oncology |
| Blujepa | gepotidacin | General medicines | Infectious diseases |
| Boostrix | diphtheria, tetanus, acellular pertussis | Vaccines | Infectious diseases |
| Cabenuva/Vocabria + Rekambys | cabotegravir, rilpivirine | Specialty medicines | HIV |
| Cervarix | HPV 16 & 18 virus like particles (VLPs), AS04 adjuvant (MPL + aluminium hydroxide) | Vaccines | Infectious diseases |
| Dovato | dolutegravir/lamivudine | Specialty medicines | HIV |
| Flixotide / Flovent | fluticasone propionate | General medicines | Respiratory, Immunology and Inflammation |
| Fluarix | split inactivated influenza antigens (2 virus subtypes A and 2 subtype B) | Vaccines | Infectious diseases |
| FluLaval | split inactivated influenza antigens (2 virus subtypes A and 2 subtype B) | Vaccines | Infectious diseases |
| Infanrix/Pediarix | diphtheria, tetanus, pertussis, polio, hepatitis B, haemophilus influenzae type B (EU) | Vaccines | Infectious diseases |
| Jemperli | dostarlimab | Specialty medicines | Oncology |
| Juluca | dolutegravir/rilpivirine | Specialty medicines | HIV |
| Lamictal | lamotrigine | General medicines | Other |
| Menveo | meningococcal group A, C, W-135 and Y conjugate vaccine | Vaccines | Infectious diseases |
| Nucala | mepolizumab | Specialty medicines | Respiratory, Immunology and Inflammation |
| Ojjaara/Omjjara | momelotinib | Specialty medicines | Oncology |
| Penmenvy | meningococcal groups A, B, C, W, and Y vaccine | Vaccines | Infectious diseases |
| Priorix, Priorix Tetra, Varilrix | live attenuated MMR, varicella and MMRV vaccines | Vaccines | Infectious diseases |
| Relvar/Breo Ellipta | fluticasone furoate/vilanterol trifenatate | General medicines | Respiratory, Immunology and Inflammation |
| Rotarix | human rotavirus RIX4414 strain | Vaccines | Infectious diseases |
| Rukobia | fostemsavir | Specialty medicines | HIV |
| Seretide / Advair | salmeterol xinofoate, fluticasone propionate | General medicines | Respiratory, Immunology and Inflammation |
| Shingrix | zoster vaccine recombinant, adjuvanted | Vaccines | Infectious diseases |
| Synflorix | conjugated pneumococcal polysaccharide | Vaccines | Infectious diseases |
| Tivicay | dolutegravir | Specialty medicines | HIV |
| Trelegy Ellipta | fluticasone furoate/vilanterol trifenatate/umeclidinium bromide | General medicines | Respiratory, Immunology and Inflammation |
| Triumeq | dolutegravir, lamivudine and abacavir | Specialty medicines | HIV |
| Ventolin | salbutamol sulphate | General medicines | Respiratory, Immunology and Inflammation |
| Xevudy | sotrovimab | Specialty medicines | Infectious diseases |
| Zejula | niraparib | Specialty medicines | Oncology |
The listing on this page is in line with the information provided in our 2024 Annual Report, with the exception of: Penmenvy - added February 2025; Blujepa - added March 2025.
